Plegicol

Plegicol

citicoline

Manufacturer:

Ikapharmindo
Concise Prescribing Info
Contents
Citicoline
Indications/Uses
Unconsciousness due to brain damage, head injury or brain surgery & cerebral infarction. Accelerates rehabilitation of upper extremities in apoplectic hemiplegic patients. Mild paralysis of lower extremities w/in 1 yr & receiving usual oral treatment. Manage the reduction of cognitive function in elderly.
Dosage/Direction for Use
Unconsciousness due to head injury or brain surgery 500 mg drip or IV 1-2 times daily. Unconsciousness in acute cerebral infarction 1,000 mg IV once daily continuously for 2 wk. Post-apoplectic hemiplegia 1,000 mg IV once daily continuously for 4 wk. Continue for additional 4 wk if there is tendency of recovery.
Contraindications
Hypertonia of the parasympathetic nervous system.
Special Precautions
Acute, severe & progressive consciousness disturbance; concomitant therapy w/ hemostatic or intracranial pressure-relieving drugs or use of measures to keep body temp low. Avoid high doses in intracranial bleeding.
Adverse Reactions
Epigastric distress, nausea; skin redness; headache, dizziness.
Drug Interactions
Phenytoin effect is reduced in the presence of alcohol & phenobarbitone.
ATC Classification
N06BX06 - citicoline ; Belongs to the class of other psychostimulants and nootropics.
Presentation/Packing
Form
Plegicol inj 125 mg/mL
Packing/Price
4 mL x 5 × 1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in